{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:10:41Z","timestamp":1790136641727,"version":"4.0.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/mao.0b013e3181b2364c","type":"journal-article","created":{"date-parts":[[2009,8,19]],"date-time":"2009-08-19T07:13:09Z","timestamp":1250665989000},"page":"835-841","source":"Crossref","is-referenced-by-count":72,"title":["Concordance of Bilateral Vestibular Schwannoma Growth and Hearing Changes in Neurofibromatosis 2"],"prefix":"10.1097","volume":"30","author":[{"given":"Laurel M.","family":"Fisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joni K.","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Lev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Slattery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-25-20210212","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2.","volume":"363","author":"Rouleau","year":"1993","journal-title":"Nature"},{"key":"R3-25-20210212","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","article-title":"A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.","volume":"72","author":"Trofatter","year":"1993","journal-title":"Cell"},{"key":"R4-25-20210212","first-page":"331","article-title":"Type of mutation in the neurofibromatosis type 2 gene(NF2) frequently determines severity of disease.","volume":"59","author":"Ruttledge","year":"1996","journal-title":"Am J Hum Genet"},{"key":"R5-25-20210212","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jmg.35.6.450","article-title":"Genotype\/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations.","volume":"35","author":"Evans","year":"1998","journal-title":"J Med Genet"},{"key":"R6-25-20210212","first-page":"69","article-title":"A mutation in the Neurofibromatosis Type 2 tumor-suppressor gene, giving rise to widely different clinical phenotypes in 2 unrelated individuals.","volume":"55","author":"Bourn","year":"1994","journal-title":"Am J Hum Genet"},{"key":"R7-25-20210212","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ajmg.1320520411","article-title":"Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity.","volume":"52","author":"Parry","year":"1994","journal-title":"Am J Med Genet"},{"key":"R8-25-20210212","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1086\/302938","article-title":"Phenotypes of patients with \"simple\" Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics.","volume":"66","author":"Dipple","year":"2000","journal-title":"Am J Hum Genet"},{"key":"R9-25-20210212","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/mgme.2000.3052","article-title":"Modifier genes convert \"simple\" Mendelian disorders to complex traits.","volume":"71","author":"Dipple","year":"2000","journal-title":"Mol Genet and Metab"},{"key":"R10-25-20210212","first-page":"216","article-title":"A review of acoustic tumors: 1983-1988.","volume":"11","author":"Brackmann","year":"1990","journal-title":"Am J Otol"},{"key":"R11-25-20210212","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/lary.5541030412","article-title":"The changing clinical presentation of acoustic tumors in the MRI era.","volume":"103","author":"Selesnick","year":"1993","journal-title":"Laryngoscope"},{"key":"R12-25-20210212","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00129492-200409000-00027","article-title":"Vestibular schwannoma growth rates in Neurofibromatosis type 2 Natural History Consortium subjects.","volume":"25","author":"Slattery","year":"2004","journal-title":"Otol Neurotol"},{"key":"R13-25-20210212","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00005537-200004000-00002","article-title":"Natural history of acoustic neuromas.","volume":"110","author":"Rosenburg","year":"2000","journal-title":"Laryngoscope"},{"key":"R14-25-20210212","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/000348940111000406","article-title":"Assessment of vestibular schwannoma growth: application of a new measuring protocol to the results of a longitudinal study.","volume":"110","author":"Stipkovits","year":"2001","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R15-25-20210212","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archotol.1980.00790360007003","article-title":"Bilateral acoustic tumors.","volume":"106","author":"Linthicum","year":"1980","journal-title":"Arch Otolaryngol"},{"key":"R16-25-20210212","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00129492-200403000-00012","article-title":"Hearing changes after diagnosis in Neurofibromatosis type 2.","volume":"25","author":"Masuda","year":"2004","journal-title":"Otol Neurotol"},{"key":"R17-25-20210212","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1097\/00005537-200011000-00015","article-title":"Tumor growth and audiometric change in vestibular schwannomas managed conservatively.","volume":"110","author":"Massick","year":"2000","journal-title":"Laryngoscope"},{"key":"R18-25-20210212","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/00129492-200307000-00022","article-title":"Magnetic resonance imaging scanner reliability for measuring changes in vestibular schwannoma size.","volume":"24","author":"Slattery","year":"2003","journal-title":"Otol Neurotol"},{"key":"R19-25-20210212","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors.","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R20-25-20210212","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.mao.0000169048.15889.80","article-title":"MRI evaluation of neorofibromatosis 2 patients: a standardized approach for accuracy in interpretation.","volume":"26","author":"Slattery","year":"2005","journal-title":"Otol Neurotol"},{"key":"R21-25-20210212","first-page":"2051","article-title":"Mosaicism in sporadic Neurofibromatosis 2 patients.","volume":"7","author":"Kluwe","year":"1998","journal-title":"Hum Med Genet"},{"key":"R22-25-20210212","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/00005537-199606000-00007","article-title":"Growth rate characteristics of acoustic neuromas associated with Neurofibromatosis type 2.","volume":"106","author":"Abaza","year":"1996","journal-title":"Laryngoscope"},{"key":"R23-25-20210212","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3171\/jns.2002.96.2.0223","article-title":"Vestibular schwannoma growth in patients with neurofibromatosis type 2: a longitudinal study.","volume":"96","author":"Mautner","year":"2002","journal-title":"J Neurosurg"},{"key":"R24-25-20210212","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3171\/jns.2002.96.2.0217","article-title":"Predictors of vestibular schwannoma growth in patients with neurofibromatosis type 2.","volume":"96","author":"Baser","year":"2002","journal-title":"J Neurosurg"},{"key":"R25-25-20210212","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/sj.mp.4001547","article-title":"Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach.","volume":"9","author":"Ogden","year":"2004","journal-title":"Molecular Psychiatry"},{"key":"R26-25-20210212","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1023\/B:BOLI.0000031100.26546.6e","article-title":"After the genome-the phenome?","volume":"27","author":"Scriver","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"R27-25-20210212","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00129492-200403000-00013","article-title":"Expression of neuregulin and activation of erbB receptors in vestibular schwannomas: possible autocrine loop stimulation.","volume":"25","author":"Hansen","year":"2004","journal-title":"Otol Neurotol"},{"key":"R28-25-20210212","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1080\/00016480050218681","article-title":"Clinicopathologic growth factors in vestibular schwannomas: a morphologic and immunohistochemical study on 69 tumors.","volume":"120","author":"Labit-Bouvier","year":"2000","journal-title":"Acta Otolaryngol"},{"key":"R29-25-20210212","first-page":"30","article-title":"Expression of Ki-67 antigen and vascular endothelial growth factor in sporadic and neurofibromatosis type 2-associated schwannomas.","volume":"22","author":"Saito","year":"2003","journal-title":"Clin Neuropathol"},{"key":"R30-25-20210212","first-page":"1","article-title":"Acoustic neuroma\/vestibular schwannoma in vivo and in vitro growth models. A clinical and experimental study.","volume":"530","author":"Charabi","year":"1997","journal-title":"Acta Otolaryngol Suppl"},{"key":"R31-25-20210212","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1097\/00005537-200312000-00014","article-title":"Immunohistochemical demonstration of VEGF in vestibular schwannomas correlates to tumor growth rate.","volume":"113","author":"Caye-Thomasen","year":"2003","journal-title":"Laryngoscope"},{"key":"R32-25-20210212","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00129492-200501000-00017","article-title":"VEGF and VEGF Receptor-1 concentration in vestibular schwannoma homogenates correlates to tumor growth rate.","volume":"26","author":"Caye-Thomasen","year":"2005","journal-title":"Otol Neurotol"}],"container-title":["Otology & Neurotology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MAO.0b013e3181b2364c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T23:08:42Z","timestamp":1710544122000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00129492-200909000-00025"}},"subtitle":["Neurofibromatosis 2 Natural History Consortium"],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mao.0b013e3181b2364c","relation":{},"ISSN":["1531-7129"],"issn-type":[{"value":"1531-7129","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}